Rituxan Hycela (rituximab/hyaluronidase human) 1400 mg and 23400 Units Single-Dose Vial **Refrigerated Shop By Product ClearVisc's mechanism of action hinges

ClearVisc's mechanism of action hinges on its unique viscoelastic properties

Precise coagulation and hemostasis of small vessels during minor surgical

saturated with 70% isopropyl alcohol

This vitamin D analog works by regulating skin cell production and differentiation

Rituxan Hycela (rituximab/hyaluronidase human) 1400 mg and 23400 Units Single-Dose Vial **Refrigerated Shop By Product ClearVisc's mechanism of action hingesRituxan Hycela (rituximab hyaluronidase human) 1400 mg and 23,400 units is used to treat specific blood cancers and autoimmune conditions. It combines rituximab, which targets CD20 positive B cells, with hyaluronidase to enhance absorption and allow subcutaneous administration. It is primarily indicated for Non Hodgkins Lymphoma and Chronic Lymphocytic Leukemia. By depleting B cells, Rituxan Hycela helps in reducing disease activity, providing a